Lachlan Campbell

Lachlan Campbell currently serves as the Vice President of Intellectual Property at Monte Rosa Therapeutics since June 2023. Prior to this, extensive experience was gained at Novartis, where roles included Global Franchise Head of R&D Intellectual Property, overseeing various research groups, and NIBR Patents European Chemistry Head, managing a team of practitioners. Earlier positions included Senior Patent Attorney, Patent Attorney at AstraZeneca, and Patent Counsel at GSK, as well as Trainee Patent Agent at Urquhart-Dykes & Lord LLP. Academic credentials include a PhD in Cell/Cellular and Molecular Biology and a Master's in the Management of Intellectual Property from Queen Mary University of London.